BioLife Solutions to Report First Quarter 2017 Financial Results and Provide Business Update on May 11, 2017

BOTHELL, Wash., May 4, 2017

To access the webcast, log on to the Investor Relations page of the BioLife Solutions website at www.biolifesolutions.com. Alternatively, you may access the live conference call by dialing (844) 825-0512 (U.S. & Canada) or (315) 625-6880 (International) with the following Conference ID:   17308601. A webcast replay will be available approximately two hours after the call and will be archived on www.biolifesolutions.com for 90 days.

About BioLife Solutions

The Company's proprietary HypoThermosol^® and CryoStor^® platform of solutions are highly valued in the biobanking, drug discovery, and regenerative medicine markets. BioLife's biopreservation media products are serum-free and protein-free, fully defined, and are formulated to reduce preservation-induced cell damage and death. BioLife's enabling technology provides commercial companies and clinical researchers significant improvement in shelf life and post-preservation viability and function of cells, tissues, and organs. 

For more information please visit www.biolifesolutions.com, and follow BioLife on Twitter.

Media & Investor Relations ARIVA.DE Börsen-Geflüster Kurse BioLife Solutions 15,83 $ -0,19%
Roderick de Greef
Chief Financial Officer
(425) 402-1400
rdegreef@biolifesolutions.com

To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/biolife-solutions-to-report-first-quarter-2017-financial-results-and-provide-business-update-on-may-11-2017-300450021.html

SOURCE BioLife Solutions, Inc.